Workflow
Mettler-Toledo(MTD)
icon
Search documents
Seeking Clues to Mettler-Toledo (MTD) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
ZACKS· 2025-04-30 14:20
Core Viewpoint - Mettler-Toledo (MTD) is expected to report a quarterly earnings per share (EPS) of $7.90, reflecting an 11.1% year-over-year decline, with revenues projected at $875.01 million, down 5.5% from the previous year [1]. Earnings Estimates - The consensus EPS estimate has remained unchanged over the past 30 days, indicating that analysts have not revised their projections during this period [2]. - Revisions to earnings projections are crucial for predicting investor behavior and are linked to short-term stock price performance [3]. Revenue and Sales Projections - Analysts estimate 'Net sales- Products' at $670.72 million, representing a 4.3% decline year-over-year [5]. - 'Net sales- Service (Point in Time+Over Time)' is projected to be $208.59 million, indicating a 7.3% decrease from the year-ago quarter [5]. - 'Net sales- Retail' is expected to reach $42.69 million, reflecting a 13% year-over-year decline [5]. - 'Net sales- Industrial' is forecasted at $332.70 million, showing a 5.4% decrease from the prior-year quarter [6]. - 'Net sales- Laboratory' is anticipated to be $495.28 million, indicating a 5.7% decline from the previous year [6]. Stock Performance - Mettler-Toledo shares have experienced a return of -7.9% over the past month, compared to a -0.2% change in the Zacks S&P 500 composite [6]. - The company holds a Zacks Rank of 3 (Hold), suggesting it is expected to perform in line with the overall market in the near future [6].
Mettler-Toledo: The Spoils Of Dominating A Niche
Seeking Alpha· 2025-04-05 07:32
Core Insights - Mettler-Toledo (NYSE: MTD) is viewed as an interesting investment opportunity, particularly influenced by recent tariff changes [1]. Company Overview - Mettler-Toledo has been followed for a couple of years, indicating a long-term interest in the company's performance and potential [1]. Investment Decision - The decision to invest in Mettler-Toledo was made recently, suggesting a strategic move based on current market conditions [1].
Here's Why Mettler-Toledo (MTD) is a Strong Growth Stock
ZACKS· 2025-03-18 14:46
Company Overview - Mettler-Toledo International Inc. is the world's largest manufacturer and marketer of weighing instruments for laboratory, industrial, and food retailing applications, focusing on high value-added segments of the weighing instruments market [11]. Investment Ratings - Mettler-Toledo is currently rated as a 3 (Hold) on the Zacks Rank, with a VGM Score of B, indicating a moderate investment outlook [11]. Growth Potential - The company is considered a top pick for growth investors, with a Growth Style Score of B, forecasting year-over-year earnings growth of 3.7% for the current fiscal year [12]. - In the last 60 days, five analysts have revised their earnings estimates upwards, with the Zacks Consensus Estimate increasing by $0.47 to $42.64 per share [12]. - Mettler-Toledo has an average earnings surprise of 8.1%, suggesting a strong performance relative to expectations [12].
Why Mettler-Toledo (MTD) is a Top Growth Stock for the Long-Term
ZACKS· 2025-02-27 15:46
Company Overview - Mettler-Toledo International Inc. is the world's largest manufacturer and marketer of weighing instruments for laboratory, industrial, and food retailing applications, focusing on high value-added segments of the market [11]. Investment Ratings - Mettler-Toledo has a Zacks Rank of 3 (Hold) and a VGM Score of B, indicating a moderate investment outlook [11]. Growth Potential - The company is considered a top pick for growth investors, with a Growth Style Score of B, forecasting year-over-year earnings growth of 3.5% for the current fiscal year [12]. - In the last 60 days, four analysts have revised their earnings estimates upwards for fiscal 2025, with the Zacks Consensus Estimate increasing by $0.30 to $42.56 per share [12]. - Mettler-Toledo has an average earnings surprise of 8.1%, suggesting a strong performance relative to expectations [12].
Why Mettler-Toledo (MTD) is a Top Momentum Stock for the Long-Term
ZACKS· 2025-02-13 15:56
Core Insights - Zacks Premium offers various tools for investors to enhance their stock market engagement and confidence [1] - The Zacks Style Scores are designed to help investors identify stocks with the potential to outperform the market in the short term [2] Zacks Style Scores Overview - The Style Scores consist of four categories: Value Score, Growth Score, Momentum Score, and VGM Score, each focusing on different investment strategies [3][4][5][6] - Value Score identifies undervalued stocks using financial ratios [3] - Growth Score emphasizes a company's financial health and future growth potential [4] - Momentum Score tracks price trends to capitalize on upward or downward movements [5] - VGM Score combines all three styles to provide a comprehensive assessment of stocks [6] Zacks Rank and Performance - The Zacks Rank is a proprietary model that uses earnings estimate revisions to assist in portfolio building [7] - Stocks rated 1 (Strong Buy) have historically achieved an average annual return of +25.41% since 1988, significantly outperforming the S&P 500 [8] - Investors are encouraged to focus on stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B for optimal returns [9] Stock Highlight: Mettler-Toledo International Inc. - Mettler-Toledo is the largest manufacturer of weighing instruments, focusing on high value-added segments [11] - Currently rated 3 (Hold) with a VGM Score of B, Mettler-Toledo has a Momentum Style Score of A and has seen a 2.6% increase in shares over the past month [11][12] - Recent upward revisions in earnings estimates for fiscal 2025 indicate positive momentum, with the Zacks Consensus Estimate rising by $0.30 to $42.56 per share [12]
Compared to Estimates, Mettler-Toledo (MTD) Q4 Earnings: A Look at Key Metrics
ZACKS· 2025-02-08 02:01
Core Insights - Mettler-Toledo reported a revenue of $1.05 billion for Q4 2024, marking an 11.8% year-over-year increase and exceeding the Zacks Consensus Estimate of $1.01 billion by 3.51% [1] - The company's EPS for the same quarter was $12.41, up from $9.40 a year ago, representing a surprise of 6.16% compared to the consensus estimate of $11.69 [1] Revenue Breakdown - Product net sales reached $801.41 million, surpassing the average estimate of $776.33 million, with a year-over-year increase of 13% [4] - Service net sales amounted to $243.72 million, exceeding the average estimate of $232.69 million, reflecting a year-over-year growth of 7.9% [4] - Retail net sales were reported at $43.86 million, below the average estimate of $46.93 million, indicating a decline of 14.6% year-over-year [4] - Industrial net sales totaled $398.41 million, slightly above the estimated $393.45 million, with a year-over-year increase of 7.6% [4] - Laboratory net sales reached $602.86 million, exceeding the average estimate of $568.55 million, representing a year-over-year growth of 17.5% [4] Stock Performance - Mettler-Toledo shares have returned 8.9% over the past month, outperforming the Zacks S&P 500 composite's 1.9% change [3] - The stock currently holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the broader market in the near term [3]
Mettler-Toledo(MTD) - 2024 Q4 - Earnings Call Transcript
2025-02-07 17:23
Financial Data and Key Metrics Changes - Sales in Q4 2024 were $1.045 billion, representing a 12% increase in local currency and US dollars [11] - Adjusted EPS for the quarter was $12.41, a 32% increase over the prior year [19] - Gross margin was 61.2%, an increase of 220 basis points due to higher volume and positive price realization [17] Business Line Data and Key Metrics Changes - Laboratory sales increased 18% in Q4, while Industrial grew 8% [14] - Food Retail declined 14% in the quarter, with service sales increasing 8% in local currency [15] - For the full year 2024, Laboratory sales increased 6%, and Industrial increased 1%, with Food Retail decreasing 14% [16] Market Data and Key Metrics Changes - Local currency sales grew 19% in Europe, 7% in the Americas, and 14% in Asia/Rest of World for Q4 [12] - Local currency sales in China increased by 4% in Q4, but decreased 11% for the full year [13] - For the full year 2024, local currency sales increased 3% in the Americas, 8% in Europe, and declined 1% in Asia/Rest of World [13] Company Strategy and Development Direction - The company aims to drive growth in 2025 by focusing on automation, digitalization, and high-growth areas [9] - Continued investment in innovation and service growth initiatives is planned to enhance market leadership [40][41] - The company is implementing strategies with a balance of growth, innovation, and operational excellence [43] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about gradual market improvement in 2025 despite uncertainties [22][38] - The company remains cautious regarding the geopolitical situation, particularly in China, but believes it has a strong competitive position [54][56] - Management noted that customer demand in biopharma and laboratory products has improved, contributing to growth [30][66] Other Important Information - Adjusted free cash flow amounted to $900.6 million in 2024, representing over 100% of adjusted net income [21] - The company expects local currency sales growth of approximately 3% for 2025, with adjusted EPS projected between $42.35 and $43 [26][28] Q&A Session Summary Question: Q4 performance and underlying growth rate - Management acknowledged strong Q4 results but indicated that underlying growth might be mid-single digits for Q1 due to various factors [46][52] Question: Competitive landscape in China - Management stated that they have a strong competitive position in China, with local manufacturing and R&D teams [54][56] Question: Industrial business outlook - Management remains cautious about core Industrial growth but is optimistic about product inspection performance [62][63] Question: Strength in Lab business and extrapolation to other markets - Management noted that strong demand in Europe could translate to better performance in the US, with a focus on replacement business [90][92] Question: Tariff impacts and mitigation strategies - Management confirmed that they have accounted for potential tariff impacts in their guidance and are prepared to adjust pricing and supply chain strategies [99][130]
Mettler-Toledo Q4 Earnings Top Estimates, Sales Up Y/Y, Shares Rise
ZACKS· 2025-02-07 16:51
Mettler-Toledo International (MTD) reported fourth-quarter 2024 adjusted earnings of $12.41 per share, which beat the Zacks Consensus Estimate by 6.16%. The bottom line jumped 32% on a year-over-year basis.See the Zacks Earnings Calendar to stay ahead of market-making news.Net sales of $1.045 billion surpassed the Zacks Consensus Estimate by 3.51%. The figure rose 12% both on a reported and local currency basis from the year-ago quarter.MTD shares were up 2.8% in pre-market trading. The stock appreciated 10 ...
Mettler-Toledo(MTD) - 2024 Q4 - Annual Report
2025-02-07 16:47
Financial Liabilities and Assets - As of December 31, 2024, the company reported a net liability of $3.2 million from cross currency swap agreements, with a potential market value change of approximately $7.0 million for a 100-basis-point change in interest rates and foreign currency exchange rates [270]. - The valuation allowance for deferred tax assets was $73.2 million as of December 31, 2024, based on management's estimates of future taxable income [273]. - The company’s consolidated balance sheet included goodwill of $668.9 million and other intangible assets of $257.1 million as of December 31, 2024 [280]. - The company has not recognized any impairment of goodwill or indefinite-lived intangible assets to date, but future assessments may be required if operating performance declines [284]. Pension and Benefit Obligations - The net periodic pension cost for the U.S. pension plan was $3.0 million for 2024, while the projected benefit obligation was $99.9 million [276]. - The expected post-retirement benefit obligation for the U.S. post-retirement medical benefit plan was $0.5 million as of December 31, 2024 [276]. - A change in the rate of return of 1% would impact annual benefit plan expense by approximately $8.7 million after tax [278]. - The weighted average discount rate assumption was 5.34% for the U.S. plan, with a 1% change impacting annual benefit plan expense by approximately $8.5 million after tax [279]. Taxation and Earnings - Based on earnings before taxes of $1.0 billion for the year ended December 31, 2024, each increase of $10.4 million in tax expense would increase the effective tax rate by 1% [275]. - The company plans to repatriate earnings from multiple countries, expecting additional tax costs associated with non-U.S. withholding taxes and U.S. taxes on currency gains [274].
Mettler-Toledo(MTD) - 2024 Q4 - Earnings Call Presentation
2025-02-07 15:47
Earnings Call Webcast February 7, 2025 Mettler-Toledo International Inc. Q4 2024 Financial Results Sales by Geography Safe Harbor Statement 2 Statements in this presentation which are not historical facts constitute "forward looking statements" within the meaning of Section 27A of the U.S. Securities Act of 1933 and Section 21E of the U.S. Securities Exchange Act of 1934. These statements involve known and unknown risks, uncertainties and other factors that may cause our or our businesses, actual results, l ...